Long Non-Coding RNAs in Liver Cancer and Nonalcoholic Steatohepatitis

Overview

Journal Noncoding RNA

Date 2020 Sep 3

PMID 32872482

Citations 6

Authors

Shizuka Uchida

Sakari Kauppinen

Affiliations

Soon will be listed here.

Abstract

This review aims to highlight the recent findings of long non-coding RNAs (lncRNAs) in liver disease. In particular, we focus on the functions of lncRNAs in hepatocellular carcinoma (HCC) and non-alcoholic steatohepatitis (NASH). We summarize the current research trend in lncRNAs and their potential as biomarkers and therapeutic targets for the treatment of HCC and NASH.

Citing Articles

Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs.

Mukherjee A, Wanjari U, Gopalakrishnan A, Katturajan R, Kannampuzha S, Murali R Cells. 2022; 11(24).

PMID: 36552725 PMC: 9777112. DOI: 10.3390/cells11243959.

Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials.

Khan A, Zhang X Bioengineering (Basel). 2022; 9(8).

PMID: 36004931 PMC: 9405066. DOI: 10.3390/bioengineering9080406.

The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.

Malagraba G, Yarmohammadi M, Javed A, Barcelo C, Rubio-Tomas T Biomolecules. 2022; 12(3).

PMID: 35327654 PMC: 8946813. DOI: 10.3390/biom12030462.

Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases.

Formichi C, Nigi L, Grieco G, Maccora C, Fignani D, Brusco N Int J Mol Sci. 2021; 22(14).

PMID: 34299336 PMC: 8306942. DOI: 10.3390/ijms22147716.

Emerging role of lncRNA ELDR in development and cancer.

Sur S, Ray R FEBS J. 2021; 289(11):3011-3023.

PMID: 33860640 PMC: 11827507. DOI: 10.1111/febs.15876.

References

Dai W, Dai J, Tang M, Ye M, Fang S . lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis. World J Gastroenterol. 2019; 25(38):5789-5799. PMC: 6801192. DOI: 10.3748/wjg.v25.i38.5789. View

Wang X, Goodrich K, Gooding A, Naeem H, Archer S, Paucek R . Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines. Mol Cell. 2017; 65(6):1056-1067.e5. DOI: 10.1016/j.molcel.2017.02.003. View

Naganuma T, Nakagawa S, Tanigawa A, Sasaki Y, Goshima N, Hirose T . Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012; 31(20):4020-34. PMC: 3474925. DOI: 10.1038/emboj.2012.251. View

Zhu X, Li H, Wu Y, Zhou J, Yang G, Wang W . lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression. Int J Mol Med. 2018; 43(1):345-357. PMC: 6257836. DOI: 10.3892/ijmm.2018.3975. View

Fang P, Xiang L, Chen W, Li S, Huang S, Li J . LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3. Innate Immun. 2019; 25(2):99-109. PMC: 6830859. DOI: 10.1177/1753425919827632. View

Guo Y, Bai M, Lin L, Huang J, An Y, Liang L . LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother. 2019; 118:109272. DOI: 10.1016/j.biopha.2019.109272. View

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

Lim K, Maruyama R, Yokota T . Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017; 11:533-545. PMC: 5338848. DOI: 10.2147/DDDT.S97635. View

Fox A, Nakagawa S, Hirose T, Bond C . Paraspeckles: Where Long Noncoding RNA Meets Phase Separation. Trends Biochem Sci. 2018; 43(2):124-135. DOI: 10.1016/j.tibs.2017.12.001. View

10.

Springer A, Dowdy S . GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. Nucleic Acid Ther. 2018; 28(3):109-118. PMC: 5994659. DOI: 10.1089/nat.2018.0736. View

11.

Llovet J, Montal R, Sia D, Finn R . Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018; 15(10):599-616. DOI: 10.1038/s41571-018-0073-4. View

12.

Moore 4th J, Uchida S . Functional characterization of long noncoding RNAs. Curr Opin Cardiol. 2020; 35(3):199-206. PMC: 7236552. DOI: 10.1097/HCO.0000000000000725. View

13.

Yan K, Fu Y, Zhu N, Wang Z, Hong J, Li Y . Repression of lncRNA NEAT1 enhances the antitumor activity of CD8T cells against hepatocellular carcinoma via regulating miR-155/Tim-3. Int J Biochem Cell Biol. 2019; 110:1-8. DOI: 10.1016/j.biocel.2019.01.019. View

14.

Liu Z, Chen J, Zhong Y, Xie L, Li J . lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Braz J Med Biol Res. 2019; 52(10):e8631. PMC: 6753855. DOI: 10.1590/1414-431X20198631. View

15.

Dong Z, Li S, Wang X, Si L, Ma R, Bao L . lncRNA GAS5 restrains CCl-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway. Am J Physiol Gastrointest Liver Physiol. 2019; 316(4):G539-G550. DOI: 10.1152/ajpgi.00249.2018. View

16.

Yang L, Jiang J . GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b. Biomed Res Int. 2019; 2019:2973289. PMC: 6348854. DOI: 10.1155/2019/2973289. View

17.

Khvorova A, Watts J . The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol. 2017; 35(3):238-248. PMC: 5517098. DOI: 10.1038/nbt.3765. View

18.

Li S, Wang L, Sun Z, Sun S, Gao J, Ma R . LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1. Eur Rev Med Pharmacol Sci. 2019; 23(7):2768-2776. DOI: 10.26355/eurrev_201904_17550. View

19.

Wu S, Ai H, Zhang K, Yun H, Xie F . Long Non-Coding RNA EGOT Promotes the Malignant Phenotypes of Hepatocellular Carcinoma Cells and Increases the Expression of HMGA2 via Down-Regulating miR-33a-5p. Onco Targets Ther. 2020; 12:11623-11635. PMC: 6942514. DOI: 10.2147/OTT.S218308. View

20.

Hernandez J, Elahi A, Clark C, Wang J, Humphries L, Centeno B . miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma. Ann Surg Oncol. 2013; 20 Suppl 3:S625-35. DOI: 10.1245/s10434-013-3106-3. View